Mars Image

IMP GMP MANUFACTURING?

NEW GMP MANUFACTURER
OF CLINICAL TRIAL MATERIAL

Read More
Mars Image

THE CRO / CDMO SPECIALISTS

IN TOPICAL PHARMACEUTICALS

Read More
Mars Image

DON'T GET STUCK
IN THE MIDDLE

GET END-TO-END DEVELOPMENT

Read More
Mars Image

THE ONLY IVRT / IVPT

SERVICE IN THE NORDIC REGION

Read More
Mars Image

DEMONSTRATED
BIOEQUIVALENCE

FOR YOUR TOPICAL PRODUCT

Read More

About

YOUR CRO / CDMO PARTNER

Zelmic is a proven and reliable CRO / CDMO partner combining regulatory and scientific knowledge in a fast, flexible and quality-focused organization. Our experts in semisolids are focused entirely on topical formulations and drug delivery and can lead you through the entire development process. We are located in Lund, Sweden, one of the top science hubs in Europe conveniently connected with Copenhagen and Stockholm, and home to numerous life science companies.

Read more

FULL SPECTRUM OF SERVICES

Turn your ideas into effective topical drug products by taking advantage of our fast, cost-efficient, risk mitigating and GMP approved services. These range from formulation development, stability testing, analytical method development and validation, to In-Vitro Release Testing (IVRT), In-Vitro Skin Permeation Testing (IVPT) and IMP GMP Manufacturing.

PRODUCT
DEVELOPMENT

IMP GMP
Manufacture

ANALYTICAL
CHEMISTRY

PERFORMANCE
TESTING

Latest news & events

Zelmic at NLSdays 2024 – Join Us at Booth A24!

We are excited to announce that Zelmic will be exhibiting at this year’s NLSdays (Nordic Life Science Days) in Malmö! As one of the leading events in the Nordic region, NLSdays brings together key players in the life science sector, and we’re thrilled to be a part of it again this year. Visit Us at…

Read more
news image

New chapter: Zelmic Becomes Part of CTR Group through acquisition

Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.

Read more
news image
See all news